Advances in the Diagnosis and Treatment of Genitourinary Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 10 May 2024 | Viewed by 2032
Special Issue Editors
Interests: genitourinary cancer; urology oncology; point of care diagnostics; personalized treatment; immunotherapy
Special Issue Information
Dear Colleagues,
Genitourinary cancers are diseases affecting an increasingly greater number of people, the diagnosis and treatment of which are currently undergoing fast and sometimes dramatic changes due to the current landscape of suboptimal management of these diseases. A characteristic feature of urological cancer treatment is the significant heterogeneity of patients (including different stages of local advancement, different locations of metastases, the heterogeneity of pathological findings, etc.). Therefore, predicting the response to modern treatments remains the unmet need of modern urologic oncology, and new diagnostic methods, including but not limited to point-of-care diagnostics, represent a challenge to current guidelines and require verification. Additionally, further development awaits us as far as sufficient neoadjuvant and adjuvant treatment in the perioperative setting is concerned. However, recent advancements in systematic treatment, i.e., immunotherapy, have shed light on new treatment paradigms to be implemented in various clinical scenarios, including localized disease, and recent progress in minimally invasive surgical techniques has lead to revisions to the treatment of many urological tumors.
This Special Issue aims to cover these novel approaches in genitourinary cancers. We look forward to receiving your original papers and reviews related to advances in the treatment of male genitourinary cancers.
Prof. Dr. Piotr Radziszewski
Dr. Łukasz Zapała
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- genitourinary cancer
- point-of-care diagnostics
- personalized treatment
- immunotherapy
- treatment